The $15 billion ad-powered AI startup your doctor may already be using

OpenEvidence, a $15 billion AI startup, is being adopted by doctors and is backed by investors including Thrive Capital and the Mayo Clinic, with founder Nadler saying the end goal is literature-based drug discovery. Anthropic's Claude Science creator Alexander Tarashansky has joined the company, which faces competition from OpenAI and Anthropic in healthcare AI. Studies have shown mixed results, with a Mayo Clinic study finding accurate evidence-based recommendations in five sampled cases while a Nature paper found it underperformed Gemini and GPT on clinical benchmarks.